Ligustilide alleviates myocardial infarction by targeting S100A9 to inhibit neutrophil activation and attenuate the inflammatory cascade

This publication has 57 references indexed in Scilit:

• Efficacy, safety, and pharmacological mechanism of Suxiao Jiuxin Pill in acute coronary syndrome: A systematic review and network pharmacology analysis
  European Journal of Integrative Medicine, 2025
• Therapeutic Potential of Chinese Herbal Medicine and Underlying Mechanism for the Treatment of Myocardial Infarction
  Phytotherapy Research, 2024
• Engineered Macrophage Membrane‐Coated S100A9‐siRNA for Ameliorating Myocardial Ischemia‐Reperfusion Injury
  Advanced Science, 2024
• Protective effects of carvacrol on lipid profiles, oxidative stress, hypertension, and cardiac dysfunction – A comprehensive review
  Food Science & Nutrition, 2024
• A pharmacokinetic study on twenty-one compounds in rat plasma by integrating UPLC-QQQ-MS/MS with GC-MS after oral administration of Suxiao Jiuxin pill
  Arabian Journal of Chemistry, 2024
• Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
  Cellular and Molecular Life Sciences, 2023
• Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneol
  Biomedicine & Pharmacotherapy, 2023
• A Novel CEBPE Variant Causes Severe Infections and Profound Neutropenia
  Journal of Clinical Immunology, 2022
• P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction
  Basic Research in Cardiology, 2022
• A Critical Role of the Bone Marrow Envelope in Human Bone Remodeling
  Journal of Bone and Mineral Research, 2020